Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fecal Microbiota Transplantation for the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) and Mental Health Comorbidity in Young Adults: A Randomized, Double-blind, Placebo Controlled Study

NCT06297421 is registered in ClinicalTrials.gov with Shenzhen Hospital of Southern Medical University as lead sponsor.

NCT NCT06297421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06297421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fecal Microbiota Transplantation for the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) and Mental Health Comorbidity in Young Adults: A Randomized, Double-blind, Placebo Controlled Study
Lead sponsor
Shenzhen Hospital of Southern Medical University
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2024
Completion date
June 30, 2026
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fecal microbiota transplantation, irritable bowel syndrome with diarrhea, mental health issue